# EDGAR Filing Document

**Accession Number:** 0001409197
**File Stem:** 0001213900-25-076307
**Filing Date:** 2025-8
**Character Count:** 5728
**Document Hash:** c4988b3a0c07f9d50d2553615a920a9c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-076307.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001213900-25-076307

**CONFORMED SUBMISSION TYPE**: NT 10-Q

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**EFFECTIVENESS DATE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bespoke Extracts, Inc.
- **CENTRAL INDEX KEY:** 0001409197
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 204743354
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NT 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-52759
- **FILM NUMBER:** 251216205

**BUSINESS ADDRESS:**
- **STREET 1:** 12001 E. 33RD ST- UNIT O
- **CITY:** AURORA
- **STATE:** CO
- **ZIP:** 80010
- **BUSINESS PHONE:** 720-949-1143

**MAIL ADDRESS:**
- **STREET 1:** 12001 E. 33RD ST- UNIT O
- **CITY:** AURORA
- **STATE:** CO
- **ZIP:** 80010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DiMi Telematics International, Inc.
- **DATE OF NAME CHANGE:** 20120319

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIRST QUANTUM VENTURES INC
- **DATE OF NAME CHANGE:** 20071106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** First Quantum Ventures Inc
- **DATE OF NAME CHANGE:** 20070808

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 12b-25**

**NOTIFICATION OF LATE FILING**

*(Check One)*: ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K 🗷 Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

For Period Ended: <u>June 30, 2025</u>

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

☐ Transition Report on Form N-SAR

For the Transition Period Ended: ________________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

**PART I -- REGISTRANT INFORMATION**

Bespoke Extracts, Inc.

Full Name of Registrant

Former Name if Applicable

12001 E. 33rd Avenue, Unit O

Address of Principal Executive Office *(Street and Number)*

Aurora, CO, 80010

City, State and Zip Code

**PART II -- RULES 12b-25(b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

---

| | | |
|:---|:---|:---|
|  | (a) | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| <br> 🗷 | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|  | (c) | The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |

---

**PART III-- NARRATIVE**

State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The compilation, dissemination and review of the information required to be presented in the Form 10-Q for the relevant period has imposed time constraints that have rendered timely filing of the Form 10-Q impracticable without undue hardship and expense to the registrant. The registrant undertakes the responsibility to file such report no later than five days after its original prescribed due date.

**PART IV -- OTHER INFORMATION**

(1) Name and telephone number of person to contact in regard to this notification

<u>Michael Feinsod</u> <u>720</u> <u>949-1143</u> <br> (Name) (Area Code) (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes No ☐

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The Company estimates that revenue for the quarter ended June 30, 2025, increased to approximately $390,000 from $278,163 for the quarter ended June 30, 2024. The increase is due to increased sales across its product lines and service offerings. The Company is unable to provide an estimate of its net loss for the quarter ended June 30, 2025.

Bespoke Extracts, Inc.

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: <u>August 14, 2025</u> | By: | /s/ Michael Feinsod |
|  | Name: <br> Title: | Michael Feinsod<br> Chief Executive Officer |

---